Jazz Pharmaceuticals to Diversify its Portfolio with Azur Pharma Merger
By Heather Cartwright
Pharma Deals Review: Vol 2011 Issue 9 (Table of Contents)
Published: 26 Sep-2011
DOI: 10.3833/pdr.v2011.i9.1551 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In order to diversify its product portfolio, Jazz Pharmaceuticals has entered into an all-stock deal to combine with privately held Azur Pharma...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018